SOMERVILLE KURT F - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
SOMERVILLE KURT F ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$12,667,005
-2.7%
124,357
-3.6%
2.55%
+2.7%
Q2 2023$13,012,345
-2.0%
128,950
-10.7%
2.48%
+2.3%
Q1 2023$13,283,880
+2.0%
144,390
+0.5%
2.42%
-4.3%
Q4 2022$13,027,845
+11.4%
143,605
-6.7%
2.53%
+7.7%
Q3 2022$11,698,000
-10.7%
153,900
-0.7%
2.35%
-5.6%
Q2 2022$13,107,000
-7.5%
155,055
-4.0%
2.49%
+9.0%
Q1 2022$14,172,000
-7.2%
161,512
-7.5%
2.28%
+7.8%
Q4 2021$15,276,000
+3.8%
174,652
-2.9%
2.12%
-5.2%
Q3 2021$14,711,000
-10.7%
179,886
-0.4%
2.23%
-9.3%
Q2 2021$16,480,000
+6.4%
180,624
-0.3%
2.46%
+0.4%
Q1 2021$15,493,000
-8.4%
181,254
+1.2%
2.45%
-10.9%
Q4 2020$16,911,000
+9.6%
179,084
+1.0%
2.75%
+1.3%
Q3 2020$15,425,000
+0.0%
177,384
+0.5%
2.72%
-4.5%
Q2 2020$15,421,000
+6.0%
176,556
+0.1%
2.84%
-11.8%
Q1 2020$14,542,000
-10.9%
176,371
+2.3%
3.22%
+5.3%
Q4 2019$16,318,000
+8.0%
172,336
-0.9%
3.06%
+2.5%
Q3 2019$15,113,000
-5.0%
173,908
-0.2%
2.99%
-5.4%
Q2 2019$15,915,000
-7.8%
174,284
-2.9%
3.16%
-7.7%
Q1 2019$17,257,000
+12.2%
179,502
+0.1%
3.42%
-3.1%
Q4 2018$15,385,000
+0.1%
179,281
+0.5%
3.53%
+14.8%
Q3 2018$15,363,000
+16.1%
178,301
+1.8%
3.07%
+5.3%
Q2 2018$13,236,000
-5.5%
175,215
+1.1%
2.92%
-5.7%
Q1 2018$14,013,000
-7.7%
173,341
-4.1%
3.10%
-1.3%
Q4 2017$15,181,000
-9.4%
180,802
-7.3%
3.14%
-6.1%
Q3 2017$16,752,000
+3.3%
195,144
+0.5%
3.34%
+1.0%
Q2 2017$16,210,000
+14.1%
194,189
+1.5%
3.31%
+10.2%
Q1 2017$14,204,000
+0.0%
191,229
-1.9%
3.00%
-4.6%
Q4 2016$14,200,000
-8.4%
194,947
-0.8%
3.15%
-6.9%
Q3 2016$15,510,000
-0.8%
196,423
+3.7%
3.38%
-3.8%
Q2 2016$15,629,000
+17.2%
189,423
+2.9%
3.51%
+15.4%
Q1 2016$13,336,000
-15.0%
184,095
+1.0%
3.04%
-15.0%
Q4 2015$15,685,000
+1.7%
182,281
+8.7%
3.58%
-8.9%
Q3 2015$15,419,000
-7.0%
167,752
-0.5%
3.93%
+2.5%
Q2 2015$16,581,000
+0.7%
168,604
+1.0%
3.84%
+2.4%
Q1 2015$16,465,000
+19.3%
166,968
+12.1%
3.74%
+9.0%
Q4 2014$13,801,000
+47.7%
148,936
+50.0%
3.44%
-8.9%
Q3 2014$9,343,000
+2.7%
99,268
-1.2%
3.77%
+6.3%
Q2 2014$9,096,000
+5.5%
100,466
-0.9%
3.55%
+3.3%
Q1 2014$8,624,000
+0.4%
101,411
-5.1%
3.43%
+4.4%
Q4 2013$8,590,000
+0.8%
106,857
-3.8%
3.29%
-3.2%
Q3 2013$8,524,000
+8.9%
111,132
+0.4%
3.40%
+3.3%
Q2 2013$7,826,000
-1.3%
110,692
-0.5%
3.29%
+0.1%
Q1 2013$7,929,000
+11.1%
111,297
-1.3%
3.28%
+2.8%
Q4 2012$7,140,000112,7813.19%
Other shareholders
NOVARTIS A G shareholders Q1 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders